Abiopharma

🔍 Boone Cornelius (Executive)

Company: EBAY INC (EBAY)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 2,778 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 66,459.00 | transaction_form_type: 4
• Acquired 2,205 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 68,664.00 | transaction_form_type: 4
• Acquired 2,200 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 70,864.00 | transaction_form_type: 4
• Acquired 1,714 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 72,578.00 | transaction_form_type: 4
• Sold 1,038 shares of Common Stock at $109.18 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 71,540.00 | transaction_form_type: 4
• Sold 836 shares of Common Stock at $109.18 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 70,704.00 | transaction_form_type: 4
• Sold 848 shares of Common Stock at $109.18 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 69,856.00 | transaction_form_type: 4
• Sold 672 shares of Common Stock at $109.18 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 69,184.00 | transaction_form_type: 4
• Sold 2,778 shares of Restricted Stock Units -5 (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,334.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 2,205 shares of Restricted Stock Units -6 (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 15,442.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Sold 2,200 shares of Restricted Stock Units -8 (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 24,196.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3
• Sold 1,714 shares of Restricted Stock Units -10 (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 25,699.00 | transaction_form_type: 4 | Footnotes: F1, F6, F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
• F2: The reporting person received restricted stock units, 1/16th of which vests on 6/15/23, and an additional 1/16th of which vests each quarter thereafter. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
• F3: Not Applicable.
• F4: The reporting person received restricted stock units, 1/16th of which vests on 6/15/24, and an additional 1/16th of which vests each quarter thereafter. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
• F5: The reporting person received restricted stock units, 1/16th of which vests on 6/15/25, and an additional 1/16th of which vests each quarter thereafter. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
• F6: The reporting person received restricted stock units, 1/16th of which vests on 6/15/26, and an additional 1/16th of which vests each quarter thereafter. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.